Livalo Tablet, Film Coated
Product Images NDC 66869-404

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Livalo (NDC 66869-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kowa Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Livalo 01)

Chemical structure of pitavastatin calcium, the active ingredient in Livalo tablets. The diagram shows the calcium salt form with molecular components including fluorophenyl, pyridine, cyclopropyl, hydroxyl, and carboxylate groups.*

FDA Label Image

Figure 1 (Livalo 02)

Forest plot depicting treatment differences in adjusted mean percent change in LDL-C comparing various statins (atorvastatin, simvastatin, pravastatin) at different doses versus Livalo (pitavastatin calcium) at specified strengths. The plot shows treatment difference estimates with 95% confidence intervals and corresponding p-values, indicating favorability towards control or Livalo.*

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Livalo 1 mg film-coated tablets label, containing pitavastatin calcium as the active ingredient. The label notes packaging of 90 tablets, manufactured and marketed by Kowa Pharmaceuticals America, Inc. It includes storage instructions, dosing reference to full prescribing information, and barcode with NDC 66869-104-90.*

FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Livalo 2 mg pitavastatin calcium tablets film coated, oral prescription drug. The label states dosage instructions and storage conditions, with each tablet containing 2.09 mg pitavastatin calcium equivalent to 2 mg pitavastatin. The product is manufactured under license by Kowa Company, Ltd in Japan and marketed by Kowa Pharmaceuticals America, Inc. The label includes the NDC 68689-204-90 and a count of 90 tablets.*

FDA Label Image

Principal Display Panel (4 mg Tablet Bottle Label)

Label for Livalo (pitavastatin) tablets, 4 mg strength, film-coated oral tablets. The label includes dosage instructions, storage conditions, and states it is Rx only. The labeler is Kowa Pharmaceuticals America, Inc. The package contains 90 tablets and notes manufacturing and marketing information, including origins from Japan and Montgomery, Alabama.*

FDA Label Image

Principal Display Panel – Carton 2 mg (Livalo 06)

Packaging label for Livalo 2 mg film-coated tablets containing pitavastatin calcium. The carton states it contains 7 tablets and is labeled as a professional sample, not for sale. The labeler is Kowa Pharmaceuticals America, Inc. Directions for use and storage instructions are printed on the side panel.*

FDA Label Image

Principal Display Panel – Carton 4 mg (Livalo 07)

Livalo 4 mg film-coated tablets packaging label for pitavastatin calcium by Kowa Pharmaceuticals America, Inc. This professional sample package contains 7 tablets and is labeled for prescription use only. The label includes directions for use, storage instructions, and dosage information, emphasizing that each tablet contains 4.18 mg of pitavastatin calcium equivalent to 4 mg of pitavastatin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.